Related Experiment Videos
C-reactive protein and nutrition.
M Krajcovicova-Kudlackova1, P Blazicek
1Research Base of the Slovak Medical University, Institute of Preventive and Clinical Medicine, Bratislava, Slovakia. marica.kudlackova@szu.sk
Bratislavske Lekarske Listy
|March 18, 2006
Summary
Vegetarian diets significantly reduce high sensitivity C-reactive protein (hsCRP) levels, a marker for cardiovascular risk. This age-independent reduction in vegetarians is linked to anti-inflammatory compounds found in fruits and vegetables.
Area of Science:
- Nutrition Science
- Cardiovascular Health
- Biomarkers
Background:
- High sensitivity C-reactive protein (hsCRP) is a key biomarker for predicting cardiovascular risk and guiding therapeutic strategies.
- Dietary patterns can influence systemic inflammation, as indicated by hsCRP levels.
Purpose of the Study:
- To compare hsCRP concentrations between vegetarian and non-vegetarian adults.
- To investigate the relationship between diet, age, and hsCRP levels in apparently healthy individuals.
Main Methods:
- Serum hsCRP concentrations were measured in two groups: vegetarians (lacto- and lacto-ovo) and non-vegetarians consuming a mixed diet.
- Participants were apparently healthy adults aged 19-75 years.
- Statistical analysis included correlation and comparison of hsCRP levels between groups.
Main Results:
- Vegetarians exhibited significantly lower average hsCRP concentrations (0.72 ± 0.07 mg/l) compared to non-vegetarians (1.62 ± 0.12 mg/l).
- Only 0% of vegetarians had hsCRP levels >3 mg/l, versus 14% in non-vegetarians.
- Non-vegetarians showed a positive linear correlation between hsCRP and age (r=0.35, p<0.001), while vegetarians displayed a horizontal trend.
Conclusions:
- A long-term vegetarian diet, rich in fruits and vegetables, is associated with lower, age-independent hsCRP levels.
- Dietary salicylates and other anti-inflammatory compounds in plant-based foods may contribute to reduced inflammation.
- Vegetarian diets may offer a protective effect against cardiovascular risk by modulating inflammatory markers.